MENU
Advertisement
With commentary from Michael P. Thompson, PhD
Reprints
View Supplement
COAPT 5-Year Data Demonstrate Benefits of Mitral TEER, Reveal Need to Address Underlying LV Dysfunction
With commentary from Gregg Stone, MD
left-arrow Created with Sketch. Previous Article
Renal Denervation: Where We Stand After the FDA Panels
With Ajay J. Kirtane, MD, SM; Eric A. Secemsky, MD, MSc, RPVI, FACC, FSCAI, FSVM; and Taisei Kobayashi, MD
Next Article right-arrow Created with Sketch.
Modern Clinical Trials Spotlight
Insights on current trial designs, inclusivity, and next steps.
View Issue
The Cath Lab Cliff: A Warning Sign of a System in Fracture
By Joel Sauer, MBA, and Ana A. Mercurio-Pinto, MHM
CT-Guided PCI: Toward Precision in Case Triage and Procedural Planning
By Yader Sandoval, MD, and Emmanouil S. Brilakis, MD, PhD
An Interview With Nidhi Madan, MD, MPH
For Suspected Coronary Calcium Nodules, What Is Your Step-by-Step PCI Strategy?
With Shrilla Banerjee, MD, FRCP, FESC; Jimmy L. Kerrigan, MD, FSCAI, FACC; and Aditya S. Bharadwaj, MD, FACC, FSCAI
New PCI Directions
By Louis Verreault-Julien, MD
